Clinical characterization of a novel alpha1-antitrypsin null variant: PiQ0Heidelberg

Abstract

The clinical characterization of a null variant of SERPINA1 – PiQ0Heidelberg – resulting in alpha1-antitrypsin (AAT) deficiency is described. This rare mutation (c.-5+5 G > A) has been previously identified but not clinically described. The 77 year-old female patient had GOLD-3, Group B COPD, severe destructive panlobular emphysema and newly observed respiratory failure on exertion at the time the genetic analysis was performed. Serum AAT level was 0.1 g/L (reference 0.9–2.0 g/L). Isoelectric focusing showed only the Z-protein indicating that this was a null mutation. The patient has started AAT replacement. Early screening and identification of AAT deficiency would allow for earlier intervention.

Keywords

• Chronic obstructive pulmonary disease
• Alpha1-antitrypsin
• Alpha1-antitrypsin deficiency
• SERPINA1
• PiQ0Heidelberg